Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kastus is an Irish nanotechnology and advanced materials company that develops photocatalytic surface treatments for glass and related surfaces. The company was originally known for antimicrobial and antiviral coatings designed to reduce contamination on touch surfaces, glass, ceramics, and indoor environments. More recently, Kastus has expanded into anti-soiling coatings for solar-panel cover glass, positioning its technology as a permanent, embedded surface treatment that improves cleanliness and energy yield over the lifetime of the panel. Its products are materials and coating technologies rather than therapeutic drug programs, and the business appears to be commercially active as a private company headquartered in Dublin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kastus.